Israel’s Teva and Tel Aviv University have signed an R&D agreement in the fields of cancer and brain studies. Teva has also partnered with Israel’s Weizmann Institute to identify the next generation of innovative antibodies for cancer treatment.
https://www.tevapharm.com/news/Teva_and_Tel_Aviv_University_sign_a_collaboration_agreement.aspx